Company Filing History:
Years Active: 2019
Title: Innovator Sik Ii Ahn: A Pioneer in Pharmaceutical Composition
Introduction: Sik Ii Ahn is an accomplished inventor based in Gyeonggi-do, Korea, known for his contributions to the field of pharmaceuticals. With a singular but significant patent to his name, Ahn’s work focuses on the development of a unique oral pharmacological composition aimed at enhancing therapeutic efficacy.
Latest Patents: Ahn's notable patent is an oral pharmacological composition comprising a novel compound, specifically 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone. This compound is characterized by its crystalline structure that demonstrates excellent stability. The patent outlines that the composition includes, as a major ingredient, the mentioned compound or a pharmaceutically acceptable salt thereof, along with a suitable diluent and lubricant. The formulation boasts a 50% volume particle diameter ranging from 3 micrometers to 9 micrometers and a 90% volume particle diameter between 10 micrometers and 50 micrometers. It offers advantages including good stability, a high dissolution rate, improved content uniformity, and excellent pharmacokinetic properties. This makes the composition effective as a non-steroidal anti-inflammatory drug for treating inflammation or pain.
Career Highlights: Sik Ii Ahn is currently affiliated with Crystalgenomics, Inc., where he contributes to innovative pharmaceutical research. His work has the potential to impact the way anti-inflammatory medications are formulated and delivered, making significant strides in improving patient outcomes.
Collaborations: Ahn has collaborated with notable colleagues, including Byung-Ha Kim and Jae-yeon Park. Together, they have worked on advancing research and development in the pharmaceutical sector, highlighting the importance of teamwork in achieving innovative breakthroughs.
Conclusion: Sik Ii Ahn is a distinguished inventor whose research in oral pharmacological compositions exemplifies innovation in the pharmaceutical field. His patented work showcases the potential to improve treatment options for inflammation and pain, marking him as a vital contributor to medical advancements. As his contributions continue to unfold, the impact of his inventions will undoubtedly resonate within the industry and amongst patients seeking effective therapies.